Explore the words cloud of the Mini Brains project. It provides you a very rough idea of what is the project "Mini Brains" about.
The following table provides information about the project.
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH
|Coordinator Country||Austria [AT]|
|Total cost||150˙000 €|
|EC max contribution||150˙000 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2017-01-01 to 2018-06-30|
Take a look of project's partnership.
|1||INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH||AT (WIEN)||coordinator||150˙000.00|
Transferring results from animal models to humans is a major bottleneck in pharmaceutical research. This is particularly true for brain disorders, including neurodegenerative and developmental diseases. Both animal models and conventional cell culture methods fail to recapitulate the complexity of the human brain and there are fundamental differences in developmental and physiological aspects between humans and the commonly used animal models. The high attrition rate of drugs for brain disorders has led major pharmaceutical companies to severely downsize their respective departments. To overcome the inherent limitations of current in vitro and in vivo models for brain disorders, we have generated a proprietary human pluripotent stem cell-derived 3D organoid culture system, termed cerebral organoids. These cerebral organoids are ‘mini brains’ that grow in a petri dish , display discrete but interconnected brain regions and recapitulate features of human brain development. ‘Mini Brains’ can be derived from patient-specific stem cells and represent a unique opportunity for creating specific human disease models in a 3D culture. The aim of the ‘Mini Brain’ project is to investigate the commercial feasibility of cerebral organoids as a new and highly cost-effective tool in the discovery and development of therapies for neurodegenerative and developmental diseases. The use of patient-specific cerebral organoids for drug screening and validation offers an alternative to animal experiments, reducing costs and animal use and improving reliability of results, and has the potential to decrease the cost of drug development, reduce the brain disease burden and increase the rate of approved drugs for brain disorders.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MINI BRAINS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MINI BRAINS" are provided by the European Opendata Portal: CORDIS opendata.
Discovering a novel allergen immunotherapy in house dust mite allergy tolerance researchRead More
Learning from social scents: from territory to identityRead More
High throughput multiplexed trace-analyte screening for diagnostics applicationsRead More